Funding for this research was provided by:
Imperial College London Diabetes Centre, a Mubadala Health Company (IREC008)
Article History
Received: 13 December 2022
Accepted: 6 July 2023
First Online: 14 July 2023
Declarations
:
: The study was approved by Institutional Research Ethics Committee (IREC008) of Imperial College London Diabetes Centre (ICLDC). Informed consent was obtained from the parent/guardian of the children, and participation in the study could be withdrawn at any time. All the methods were performed in accordance with national guidelines and regulations, approved by ICLDC, Institutional Research Ethics Committee for ADOS study (IREC008).
: Not applicable.
: The authors declare no competing interests.